Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, Lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. As we prepare for our first commercial launch, we are seeking an experienced brand communications leader who is energized by the opportunity to build from the ground up, establish the disease and brand narrative, and shape the PR and communications ecosystem for a best-in-class launch. Reporting to the VP of Marketing, the Director, Brand Communications will be the single point of accountability for all brand PR and communications at Mineralys. This is a new role built for someone who thrives in pre-launch environments and is energized by building from the ground up — owning the narrative for Lorundrostat across HCPs, patients, advocacy organizations, and the media from pre-launch through commercialization. The role requires both strategic and executional leadership, spanning brand PR agency management, disease awareness and market shaping, advocacy and ambassador programs, and congress and launch communications. Mineralys has an established corporate communications function that owns enterprise reputation and investor relations — this role is focused entirely on brand and disease communications and requires a genuine collaborative partner mindset with that team. A strong partnership with Corporate Communications is critical to ensure alignment reinforced through a dotted-line reporting relationship to the SVP of Corporate Communications.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director